EGFR inhibitor treatment

Zhengxiang He; Lili Chen; Grace Chen; Paola Smaldini; Gerold Bongers; Jovani Catalan-Dibene; Glaucia C. Furtado; Sergio A. Lira

Improve Research Reproducibility A Bio-protocol resource

Home
Protocols

Concise Method

EGFR inhibitor treatment

ZH Zhengxiang He

LC Lili Chen

GC Grace Chen

PS Paola Smaldini

GB Gerold Bongers

JC Jovani Catalan-Dibene

GF Glaucia C. Furtado

SL Sergio A. Lira

This method is extracted from research article: Gastroenterology, Aug 2019

Interleukin 1 beta and Matrix Metallopeptidase 3 Contribute to Development of EGFR-dependent Serrated Polyps in Mouse Cecum

DOI: 10.1053/j.gastro.2019.08.025

Ask a question

Favorite

The EGFR inhibitor gefitinib (75 mg/kg, Sigma-Aldrich, St Louis, MO) were dissolved in 0.2% (vol/wt) Tween-80 (Sigma-Aldrich, St Louis, MO) and administered daily by oral gavage ⁷ for 35 days.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

Post a Question

0 Q&A

Share your protocol with your peers.

Submit a Preprint Protocol